TW209219B - - Google Patents
Download PDFInfo
- Publication number
- TW209219B TW209219B TW081105638A TW81105638A TW209219B TW 209219 B TW209219 B TW 209219B TW 081105638 A TW081105638 A TW 081105638A TW 81105638 A TW81105638 A TW 81105638A TW 209219 B TW209219 B TW 209219B
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- formula
- pyrrolo
- pyridine
- ministry
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73169191A | 1991-07-17 | 1991-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW209219B true TW209219B (esLanguage) | 1993-07-11 |
Family
ID=24940584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW081105638A TW209219B (esLanguage) | 1991-07-17 | 1992-07-16 |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0524004A1 (esLanguage) |
| JP (1) | JPH0665242A (esLanguage) |
| KR (1) | KR930002346A (esLanguage) |
| AU (1) | AU655998B2 (esLanguage) |
| CA (1) | CA2074038A1 (esLanguage) |
| FI (1) | FI923267L (esLanguage) |
| HU (2) | HUT61550A (esLanguage) |
| IE (1) | IE922314A1 (esLanguage) |
| IL (1) | IL102521A (esLanguage) |
| IT (1) | IT1256880B (esLanguage) |
| NO (1) | NO922812L (esLanguage) |
| NZ (1) | NZ243586A (esLanguage) |
| TW (1) | TW209219B (esLanguage) |
| ZA (1) | ZA925324B (esLanguage) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0411509A (pt) | 2003-06-20 | 2006-07-25 | Hoffmann La Roche | compostos, processo para a sua manufatura, composições farmacêuticas que compreendem os mesmos, método para tratamento e/ou profilaxia de enfermidades que estão associadas com dpp-iv e sua utilização |
| CN103387583B (zh) | 2012-05-09 | 2018-04-13 | 中国科学院上海药物研究所 | 二芳基并[a,g]喹嗪类化合物、其制备方法、药物组合物及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4791108A (en) * | 1987-04-13 | 1988-12-13 | Syntex (U.S.A.) Inc. | Sulfonyl-decahydro-8H-isoquino[2,1-G][1,6]-naphthyridines and related compounds useful as α2 -blockers |
-
1992
- 1992-07-16 IT ITTO920606A patent/IT1256880B/it active IP Right Grant
- 1992-07-16 KR KR1019920012695A patent/KR930002346A/ko not_active Withdrawn
- 1992-07-16 EP EP92306553A patent/EP0524004A1/en not_active Withdrawn
- 1992-07-16 TW TW081105638A patent/TW209219B/zh active
- 1992-07-16 IE IE231492A patent/IE922314A1/en not_active Application Discontinuation
- 1992-07-16 CA CA002074038A patent/CA2074038A1/en not_active Abandoned
- 1992-07-16 FI FI923267A patent/FI923267L/fi not_active Application Discontinuation
- 1992-07-16 JP JP4232571A patent/JPH0665242A/ja active Pending
- 1992-07-16 IL IL10252192A patent/IL102521A/en not_active IP Right Cessation
- 1992-07-16 ZA ZA925324A patent/ZA925324B/xx unknown
- 1992-07-16 AU AU20313/92A patent/AU655998B2/en not_active Ceased
- 1992-07-16 NO NO92922812A patent/NO922812L/no unknown
- 1992-07-16 NZ NZ243586A patent/NZ243586A/en unknown
- 1992-07-16 HU HU929202333A patent/HUT61550A/hu unknown
-
1995
- 1995-02-17 HU HU95P/P00077P patent/HU210711A9/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ITTO920606A0 (it) | 1992-07-16 |
| ZA925324B (en) | 1994-07-17 |
| ITTO920606A1 (it) | 1994-01-16 |
| HUT61550A (en) | 1993-01-28 |
| CA2074038A1 (en) | 1993-01-18 |
| FI923267A7 (fi) | 1993-01-18 |
| NO922812D0 (no) | 1992-07-16 |
| AU2031392A (en) | 1993-01-21 |
| AU655998B2 (en) | 1995-01-19 |
| FI923267L (fi) | 1993-01-18 |
| IE922314A1 (en) | 1993-01-27 |
| IL102521A (en) | 1996-05-14 |
| FI923267A0 (fi) | 1992-07-16 |
| KR930002346A (ko) | 1993-02-23 |
| HU9202333D0 (en) | 1992-10-28 |
| JPH0665242A (ja) | 1994-03-08 |
| NO922812L (no) | 1993-01-18 |
| IT1256880B (it) | 1995-12-27 |
| EP0524004A1 (en) | 1993-01-20 |
| NZ243586A (en) | 1995-03-28 |
| HU210711A9 (en) | 1995-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI338684B (en) | Tetrahydroquinoline derivatives and a process for preparing the same | |
| JP3356726B2 (ja) | ５ＨＴ１Ａリガンドとしてのピロロ［１，２−ａ］ピラジン誘導体 | |
| CN112110918A (zh) | 螺环取代的嘧啶并环类化合物，其制法与医药上的用途 | |
| CA2045359C (en) | 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines | |
| CN111867585A (zh) | 噁二唑瞬时受体电位通道抑制剂 | |
| WO2021249475A1 (zh) | 稠合喹唑啉类衍生物、其制备方法及其在医药上的应用 | |
| JP6278416B2 (ja) | 置換４−ピリドン及びそれらの好中球エラスターゼ活性阻害薬としての使用 | |
| TW201202246A (en) | Heterocyclic compounds as JANUS kinase inhibitors | |
| TW542833B (en) | Benzoxazinone dopamine D4 receptor antagonists | |
| JP6278415B2 (ja) | 置換４−ピリドン及びそれらの好中球エラスターゼ活性阻害薬としての使用 | |
| CN116354926A (zh) | 作为Polθ抑制剂的杂环化合物及其制备方法和用途 | |
| TWI444376B (zh) | 脯胺醯胺吡啶化合物、其藥學組成物及醫藥用途 | |
| US20020132811A1 (en) | 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors | |
| IE893265L (en) | Quinolinone derivatives, their preparation and their¹application in therapy | |
| EP3240783A1 (en) | New benzimidazole derivatives as antihistamine agents | |
| KR20010033609A (ko) | 테트라하이드로벤즈인돌 유도체 | |
| WO2022063303A1 (zh) | 一类并环化合物及其制备和应用 | |
| JP4505135B2 (ja) | Ｄ２及びｄ３ドーパミンならびに５ｈｔ１ａ及び５ｈｔ２セロトニンのレセプターのリガンドとしての８−アザビシクロ［３．２．１］オクタン−３−メタンアミン誘導体 | |
| TW209219B (esLanguage) | ||
| BR112015009243A2 (pt) | composto de amina cíclico fluorosubstituído, método para preparar um composto de amina cíclico fluorosubstituído, composição farmacêutica, inibidor de acetilcolinesterase e uso do composto de amina cíclico fluorosubstituído | |
| TW509692B (en) | 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo[3,2-d]pyrimidin-4-ones | |
| EA020716B1 (ru) | Производные 1-бутил-2-гидроксиаралкилпиперазина и их применение в качестве лекарственного средства против депрессии | |
| WO2024091538A1 (en) | Compounds and compositions as gpr52 modulators | |
| JPH0240381A (ja) | 新規縮合ジアゼピノン類、それらの製造方法及びこれらの化合物を含有する医薬組成物 | |
| JPH0733744A (ja) | インダゾール誘導体およびその塩 |